When Is Vasculitis Managed as an Outpatient, and When Does It Need a Hospital Stay?

The letter arrives on a Tuesday. A kidney test came back abnormal, an inflammation marker is raised, and the note from the family physician contains the word vasculitis with a question mark after it. The clinic appointment is three weeks away. Should someone be looking at this today?

That question, in one form or another, is the first one most people ask. Knowing when to see a rheumatologist for vasculitis, and when the right move is an emergency department rather than a waiting list, turns on a handful of specifics: which vessels are inflamed, which organ is at risk and how quickly things are changing.

This guide walks through those specifics the way a clinician would, without the jargon and without the alarm. It explains what the diagnosis involves, who does what, which situations sit comfortably in a clinic room and which ones belong on a ward, and what the first weeks tend to look like. Every decision along the way stays with the team treating you; the aim here is to make the conversation with that team sharper.

What vasculitis actually is, and why the size of the vessel changes everything

Vasculitis is inflammation of the wall of a blood vessel. That single sentence covers a family of conditions rather than one disease, and the family is grouped by the size of the vessel that the immune system has mistaken for a threat.

Here is the mechanism in everyday terms. White blood cells and antibodies that normally patrol for infection settle into the vessel wall. The wall swells, which narrows the channel, and the tissue downstream receives less oxygen, a bit like a garden hose with a kink in it. In some vessels the wall weakens instead and leaks, which is why a small-vessel vasculitis in the skin can show up as clusters of purplish spots that do not fade when pressed.

Large-vessel disease, such as giant cell arteritis and Takayasu arteritis, involves the aorta and its main branches. Medium-vessel disease, including polyarteritis nodosa and Kawasaki disease in children, targets the arteries that feed organs and limbs. Small-vessel disease, which includes the ANCA-associated vasculitides and IgA vasculitis, reaches the capillaries of the kidneys, lungs, nerves and skin. Johns Hopkins lays out this classification in detail, and it is worth knowing which branch you are on, because it shapes almost everything that follows.

Why does vessel size matter for the clinic-or-ward decision? Because it predicts which organs are at stake and how fast the situation can turn. Inflamed capillaries in a kidney can take a person from normal blood tests to needing dialysis within weeks, often with few symptoms along the way. Inflamed skin vessels, on the other hand, may itch and look alarming yet leave the internal organs untouched. Same word, very different urgency.

What doctor treats vasculitis, and who else joins the team?

For most adults the answer is a rheumatologist, a physician who specializes in autoimmune and inflammatory conditions of the joints, muscles and blood vessels. Vasculitis sits squarely in that territory because the problem is an immune system that has lost its sense of proportion, not a mechanical fault in the vessel itself.

The route there almost always starts somewhere else. A family physician notices protein in a urine sample or a stubbornly high inflammation marker. A dermatologist biopsies a rash that will not settle. An eye specialist sees a person with sudden visual loss and a tender scalp. An emergency physician admits someone who has coughed up blood. Each of these clinicians can recognize the pattern, order first tests and start urgent treatment, but the longer-term steering usually passes to rheumatology.

The organ under attack decides who else is involved. Kidney involvement brings in a nephrologist, a kidney specialist. Lung bleeding or nodules bring a pulmonologist. Nerve damage, which can show as numbness or weakness in a foot or hand, calls for a neurologist. Ear, nose and throat surgeons are often part of care in granulomatosis with polyangiitis, where the sinuses and airway are frequent targets. In children, Kawasaki disease and IgA vasculitis are usually managed by pediatricians with cardiology or pediatric nephrology support, as Mayo Clinic and the NHS describe.

What matters more than the title on the door is that one clinician holds the overview. Vasculitis care fails most often at handoffs: a kidney result seen by one team, a nerve symptom mentioned to another, and nobody connecting the two. Ask early who your coordinating specialist is, and make sure every other clinician knows that name.

When to see a rheumatologist for vasculitis: what usually prompts a referral

Referral is rarely triggered by a symptom on its own. It is the combination of a systemic pattern, an inflammatory blood test and a sign that an organ is involved that makes a family physician pick up the phone.

The systemic pattern is the vague part: weeks of fatigue, low-grade fevers, night sweats, weight loss without trying, aching muscles and joints. On their own these overlap with infections and dozens of other conditions. The blood tests that raise suspicion are the erythrocyte sedimentation rate, or ESR, and C-reactive protein, or CRP; both are general markers of inflammation anywhere in the body, and neither is specific to vasculitis, as MedlinePlus explains.

The organ sign is what turns suspicion into a referral. Blood or protein in the urine on a dipstick. A rash of raised, non-blanching purple spots, especially on the lower legs. New numbness or weakness in a limb. Persistent nasal crusting, nosebleeds or sinus pain that antibiotics have not touched. Coughing that produces blood. A new headache with scalp tenderness or jaw pain on chewing in someone over 50, an age pattern Mayo Clinic describes for giant cell arteritis.

Family physicians grade the urgency of that referral, and the grade is what determines whether you wait weeks or hours. Skin findings with normal urine and normal kidney function commonly go on a routine pathway. Abnormal kidney tests, lung symptoms or nerve involvement usually go as urgent, meaning days. Visual symptoms, coughing blood, stroke-like signs or rapidly climbing kidney markers bypass the referral letter altogether and go to emergency care the same day. The NHS and Mayo Clinic both frame vasculitis as a condition where early specialist assessment matters, precisely because the window to protect an organ can be short.

Can a rheumatologist help with vasculitis, or is this a whole-team job?

Both. A rheumatologist can do a great deal, and the best care comes when that specialist is anchoring a wider team rather than working alone.

The rheumatologist’s first job is to pin down what you actually have. Vasculitis mimics, and is mimicked by, infections, cancers, clotting disorders and drug reactions, so the specialist’s opening weeks are spent confirming the diagnosis, naming the type and mapping which organs are involved. That map decides the intensity of treatment; the same diagnosis in one person may be skin-limited and in another may involve the kidneys.

The second job is choosing and adjusting the immune-calming strategy. This is where experience counts, because the medicines used carry real risks of their own, and the skill lies in using enough to protect organs while limiting infection, bone loss, blood sugar problems and other side effects. Cleveland Clinic describes this balance as the central challenge of long-term vasculitis care.

The third job is surveillance. Vasculitis can relapse, sometimes years after a quiet period, and it can do so silently in the kidneys. Regular blood and urine testing, coordinated by rheumatology, is how a relapse is caught before it costs organ function.

Where the team comes in is organ-specific expertise and procedures. A kidney biopsy is done by nephrology or radiology. Plasma exchange, a procedure that filters harmful antibodies out of the blood, runs through a specialized unit. Eye examinations, lung function tests and nerve studies each belong to their own specialty. Rheumatology’s value is in reading all of those results as a single story. If you have been told you have vasculitis and no one has yet mentioned a rheumatologist, that is a fair question to raise with whoever is treating you.

What test confirms vasculitis?

No single test does, and anyone promising one is oversimplifying. Diagnosis is built from three layers: blood and urine, imaging, and tissue.

Blood and urine come first. ESR and CRP show that inflammation is present. Kidney function tests and a urine sample examined under a microscope show whether the kidneys are involved; red blood cells moulded into tiny tubes, called red cell casts, are a particularly telling finding. Antineutrophil cytoplasmic antibodies, or ANCA, are antibodies directed against a type of white blood cell, and they are strongly associated with several small-vessel vasculitides. A positive ANCA supports the diagnosis; a negative result does not exclude it. Blood cultures and hepatitis tests are usually run at the same time, because infection can produce a near-identical picture.

Imaging shows the vessels themselves. Ultrasound of the temporal arteries can reveal the thickened wall of giant cell arteritis. CT or MR angiography, scans that highlight the arteries, map narrowing and bulging in large and medium vessels. PET scanning, which detects metabolically active tissue, can light up inflamed aortic walls. Chest imaging looks for lung nodules or bleeding.

Tissue is the closest thing to confirmation. A biopsy, meaning a small sample removed for microscopic examination, of skin, kidney, temporal artery, nerve or sinus lining can show inflammatory cells inside a vessel wall, which is the defining feature. Mayo Clinic describes biopsy as the most definitive way to establish the diagnosis. Even so, inflammation is patchy, and a biopsy can miss an affected segment, so a negative sample in a convincing clinical picture does not close the case.

The practical point for the clinic-or-hospital question: when the kidneys are clearly involved and the diagnosis still rests on blood, urine and imaging alone, teams often prefer to complete the biopsy during an admission so treatment can begin without delay.

Which vasculitis cases are usually managed as an outpatient?

More than most people expect. The majority of long-term vasculitis care happens in clinic rooms, laboratories and telephone calls rather than on wards.

Skin-limited small-vessel vasculitis is the clearest example. When a biopsy confirms inflammation in skin vessels, urine and kidney tests are normal and there are no systemic symptoms, the plan is often watchful monitoring with repeat urine testing, because the internal organs are not under threat. IgA vasculitis in children, which the NHS notes usually settles on its own, is typically managed at home with scheduled urine checks in the months afterwards to catch late kidney involvement.

Giant cell arteritis is usually started as an outpatient too, provided vision is intact and treatment has begun. The NHS pathway involves urgent specialist assessment, with corticosteroid treatment started immediately and the confirming ultrasound or biopsy arranged around it. Once symptoms are settling, follow-up is clinic-based, with blood tests to track the inflammation markers.

ANCA-associated vasculitis in its maintenance phase, Takayasu arteritis in remission and polyarteritis nodosa after the acute stage all live in outpatient care as well. The rhythm looks like this: visits spaced weeks apart at first, stretching to months as things stabilize; blood counts, kidney function and urine at each visit; a lower threshold for extra tests if anything shifts.

Outpatient does not mean low intensity. It means the disease is not currently threatening an organ fast enough to need hourly observation or intravenous treatment. The trade-off is that you become part of the monitoring system. Knowing which symptoms should prompt a call between visits, and keeping the standing appointments even when you feel well, is what makes clinic-based care safe.

Which situations usually mean a hospital stay?

Admission is about pace and access, not the severity of the diagnosis in the abstract. Teams admit when an organ is failing faster than weekly clinic visits can track, or when the treatment itself has to be given intravenously and watched closely.

Kidney involvement that is moving quickly is the commonest reason. When creatinine, the blood marker of kidney filtering, rises over days rather than months, the condition is called rapidly progressive glomerulonephritis, and it can end in dialysis if not treated promptly. Admission allows daily blood tests, a kidney biopsy, intravenous immune-suppressing treatment and, in some cases, plasma exchange.

Lung hemorrhage is the most frightening. Bleeding into the air sacs causes breathlessness and coughing up blood, and oxygen levels can fall quickly. This is intensive care territory until it is controlled.

Giant cell arteritis with any visual symptom, including brief episodes of blurring or double vision, is treated as an emergency because loss of vision can become permanent and the other eye is at risk; the NHS is explicit that this needs immediate care. Stroke-like symptoms from inflamed brain vessels, severe abdominal pain suggesting gut vessels are blocked, chest pain from heart involvement and a rapidly progressing nerve palsy fall into the same category.

Children with suspected Kawasaki disease are usually admitted, as Mayo Clinic describes, because the treatment is an intravenous infusion and the aim is to protect the coronary arteries, which supply the heart, during the window when aneurysms can form.

Two quieter reasons complete the list. Serious infection in a person already on immune-suppressing treatment often needs a hospital bed, since the usual signs of infection can be muted. And diagnostic uncertainty in someone who is unwell, where the team needs a biopsy and results within a day or two rather than weeks, can justify a short admission on its own.

Clinic or ward? A side-by-side view of the signals teams weigh

Teams rarely decide on one factor. They weigh a set of signals together, and the same signal reads differently in a person who is otherwise well than in someone already short of breath. The table shows the pattern that most commonly tips the balance one way or the other.

Signal	Usually points to clinic-based care	Usually points to admission
Kidney	Normal function, no blood or protein in urine, or a stable mild abnormality	Creatinine rising over days, red cell casts, falling urine output
Lungs	No respiratory symptoms; stable nodules on imaging	Coughing blood, new breathlessness, low oxygen levels
Eyes and brain	No visual or neurological symptoms	Any visual change, stroke-like signs, severe new headache
Skin and joints only	Biopsy-confirmed skin vasculitis with normal organ tests	Infected skin ulcers, or skin findings plus any organ sign
Treatment route	Oral medicines with scheduled monitoring	Intravenous treatment, plasma exchange, close observation
Overall trajectory	Stable or improving results between visits	Results worsening faster than the follow-up interval
Infection risk	Well, no fever, on stable treatment	Fever or feeling unwell while immune-suppressed

Two caveats. First, the columns are not fixed destinations: many people move from the right-hand column to the left within a week or two once treatment takes hold, and a smaller number move the other way during a flare. Second, local practice varies. Some centers run intravenous treatments through day units that allow people home the same evening, while others prefer a short admission for the first infusion. Neither approach is wrong; the aim is identical, which is to get treatment into a threatened organ safely and watch what happens. Ask your team which pattern applies to you, and what specifically would change their mind.

Who is usually asked to wait, and when to see a rheumatologist for vasculitis urgently

Waiting is not neglect. Referral systems rank by threat to organ and life, so a person with skin-only findings and clean urine will usually be placed behind someone whose kidney markers are climbing, and that is the right order.

If you are the one waiting, the typical profile looks like this: a rash that a biopsy has shown to be small-vessel vasculitis, normal kidney tests, no blood or protein in the urine, no fever or weight loss, no lung or nerve symptoms. The plan while you wait is not passive. Ask your family physician for a repeat urine test, since kidney involvement in small-vessel disease can appear weeks after the skin. Photograph the rash with a date stamp so the specialist can see how it evolved. Note any new symptom, however minor, with the day it started.

The people who move to the front are those in whom something is changing. A single abnormal urine result becomes urgent when the next one is worse. Fatigue becomes urgent when it is joined by breathlessness. A headache becomes an emergency when vision flickers.

So when to see a rheumatologist for vasculitis urgently, rather than at the scheduled slot? The honest guide is trajectory. Stable findings can wait for a well-organized appointment. Worsening findings, or a new organ joining in, should prompt a call to the referring clinician asking for the referral to be expedited. If the new symptom is one of the red flags described later in this article, the right door is the emergency department, with the rheumatology referral catching up afterwards.

One more group deserves mention: people already diagnosed who feel a flare coming on. Most clinics offer a direct line or an advice number for exactly this. Use it rather than waiting for the next booked visit.

What the first days and weeks usually look like

The early phase moves faster than most chronic conditions. Expect a cluster of appointments, a lot of blood taken and, for many types, treatment that starts before every result is back.

For giant cell arteritis, corticosteroids are typically started the same day the diagnosis is suspected, because the goal is protecting vision and the confirming ultrasound or biopsy remains readable for several days afterwards; the NHS describes this immediate-start approach. Mayo Clinic notes that most people with giant cell arteritis begin to feel better within days of starting treatment, although feeling better is not the same as the disease being controlled, which is why blood tests continue.

For suspected ANCA-associated vasculitis with organ involvement, the first two weeks often include a biopsy, a chest scan, ANCA and kidney testing, and the start of what clinicians call induction treatment, meaning the stronger initial phase intended to switch the inflammation off. Whether that happens on a ward or through a day unit depends on the factors in the table above.

Over the following weeks the pattern usually settles into a rhythm: clinic visits with blood counts and kidney function at each, urine checks, and questions about infections, mood and sleep, since the medicines affect all three. Side effects of corticosteroids, including appetite changes, sleep disturbance and raised blood sugar, are common in this window and worth reporting rather than enduring silently.

The medium term stretches out. Induction runs for months, and maintenance treatment continues well beyond that; the NHS notes that giant cell arteritis treatment commonly continues for 1–2 years. These are typical ranges from population experience, not predictions for you. Your team will set the timeline on the basis of your results, and will change it if the disease does.

How treatment works: calming the immune system in two phases

Vasculitis treatment aims to stop the immune attack quickly, then keep it switched off with the least medicine that does the job. Clinicians describe these as induction and maintenance phases.

Corticosteroids do most of the heavy lifting in induction. They are synthetic versions of a hormone the body already makes, and they damp down inflammation broadly and fast, which is exactly what a threatened organ needs. Their drawback is that same breadth: over months they affect bone density, blood sugar, blood pressure, weight, mood and infection resistance. The strategy is therefore to use them early and then reduce them as other medicines take over, on a schedule set entirely by the prescribing team.

Other immune-suppressing medicines are the steroid-sparing partners. Some, such as cyclophosphamide, methotrexate, azathioprine and mycophenolate, slow the multiplication of immune cells in general. Others are targeted antibodies; rituximab, for example, removes the B cells that make ANCA. Which is chosen depends on the type of vasculitis, the organs involved, age, fertility plans and kidney function, and each brings its own monitoring of blood counts, liver tests and infection risk. They are named here so the terms make sense when you hear them, not as a recommendation for any one of them.

Plasma exchange filters antibodies out of the bloodstream through a machine. It is reserved for the most severe kidney or lung involvement and is one of the reasons such cases are admitted.

Alongside all of this sits protective care: bone protection, blood pressure and cholesterol management, vaccinations before immune suppression deepens, and attention to the mouth ulcers, indigestion or low mood these medicines can cause. If any medicine feels unbearable, the right response is a call to the team, never a quiet decision to stop. Abruptly stopping corticosteroids can itself be dangerous.

What people often get wrong about vasculitis care

Vasculitis attracts more misunderstanding than most diagnoses, partly because the word covers so much ground. These are the errors clinicians hear most often.

“It is one disease.” The word describes a process, inflammation in a vessel wall, that appears in a family of distinct conditions with different causes, ages of onset, organ patterns and treatments. Advice that fits one type can be wrong for another, which is why online stories from people with a different type are a poor guide to your own.

“If I felt seriously ill, I would know.” Kidney inflammation is often painless. Some people arrive at diagnosis with a biopsy showing months of damage and only tiredness to report. This is the main reason urine testing is repeated so often even when you feel fine.

“A negative ANCA test means it is not vasculitis.” ANCA is helpful, not decisive. Several types are ANCA-negative by nature, and Johns Hopkins notes that some people with ANCA-associated disease test negative. The clinical picture, imaging and biopsy carry the diagnosis together.

“Being admitted means treatment has failed.” Admission is usually about speed and intravenous access. It is often how the first, strongest phase of treatment is delivered safely, not a verdict on the plan.

“Once it is controlled, it is over.” Vasculitis can relapse, sometimes years later, as both Mayo Clinic and the NHS note. Long follow-up is not excessive caution; it is the design.

“Steroids are the dangerous part and everything else is safe.” Every immune-suppressing medicine carries infection risk and needs monitoring. The goal is the lowest total burden, not swapping one worry for another.

“I can stop the medicine when I feel better.” Feeling well is the first result of treatment, not the last. Stopping early is a common avoidable route to relapse and, with corticosteroids, can be acutely dangerous. Any change belongs in a conversation with your team.

Questions to ask your care team

Good questions do two things: they surface the information you need to live safely between visits, and they signal to the team that you want to be a partner in monitoring. Bring these written down; appointments move fast.

• Which type of vasculitis do you think I have, and how confident are you in that classification right now?
• Which of my organs show involvement, and which tests are you using to watch each one?
• What, specifically, would make you want to admit me, and what should I do if that happens at night or on a weekend?
• Who is coordinating my care across specialties, and how do I reach that person or their team between appointments?
• What is the purpose of each medicine I am taking, which side effects should I report immediately, and which are expected and manageable?
• How often will my blood and urine be tested, and who reviews the results and tells me if something changes?
• Which vaccinations should be up to date before or during treatment?
• What are the signs of a flare for my particular type, and how do they differ from side effects or ordinary illness?
• What does the likely treatment timeline look like over the next few months, and what would make it shorter or longer?
• Are there activities, travel plans or other medicines I should discuss before going ahead?

Write the answers next to each question. Bring them to every visit, together with a one-line log of any symptom, infection or missed dose since the last one. This is not busywork. Clinicians make better decisions when the person in front of them can say “the rash faded by day ten, then came back on the left ankle on day nineteen” rather than “it has been up and down.” You are the only person present at every moment of your illness; the notes make that vantage point usable.

When to call your doctor: vasculitis emergency symptoms and red flags

The most useful thing this article can leave you with is a short, clear list of when to stop reading and pick up the phone. These are reasons to seek care, not a tool for diagnosing yourself.

Call emergency services or go to an emergency department now if you have:

• Any change in vision, including brief blurring, double vision or a shadow over part of the field, especially with a new headache, scalp tenderness or jaw pain when chewing
• Coughing up blood, or breathlessness that is new or rapidly worsening
• Sudden weakness or numbness on one side, facial droop, trouble speaking, confusion or a seizure
• Severe abdominal pain, particularly with vomiting or blood in the stool
• Chest pain or a racing, irregular heartbeat
• Very little urine over a day, or swelling of the legs and face that has appeared quickly
• Fever, shaking chills or feeling very unwell while taking immune-suppressing medicine, since infection can progress rapidly when the immune system is damped down

Contact your rheumatology team or family physician the same day, or on the next working day if it is safe, for:

• New blood in the urine, foamy urine, or a rash that is spreading or ulcerating
• New numbness, tingling or foot drop
• Nosebleeds, ear pain or sinus symptoms that are worsening
• Return of fatigue, fever, night sweats or weight loss after a stable period
• Side effects that are making it hard to take medicines as prescribed

When to seek care, in one paragraph: if a symptom is new, involves your eyes, breathing, brain, heart or kidneys, or is getting worse hour by hour, do not wait for a booked appointment. The NHS and Mayo Clinic both describe vasculitis as a condition where prompt treatment can prevent lasting organ damage, and the emergency department is the fastest route to that treatment. Everything else, including whether to continue, change or stop any medicine, is a decision for you and your treating team together, and never one to make alone on a difficult night.

Frequently asked questions

Can a rheumatologist help with vasculitis?

Yes. Rheumatologists are the specialists who most often confirm the type of vasculitis, choose and adjust immune-suppressing treatment, monitor for relapse and coordinate the other specialists involved. Because vasculitis can affect kidneys, lungs, eyes and nerves, the rheumatologist usually works alongside nephrology, pulmonology, ophthalmology or neurology, but typically holds the overall plan. If you have been given the diagnosis and no rheumatologist is involved, it is reasonable to ask why.

What type of doctor should I see for vasculitis?

Start with your family physician, who can order the first blood and urine tests and grade how urgent a referral is. The specialist who usually takes over is a rheumatologist. Depending on which organ is affected you may also see a kidney specialist, lung specialist, eye specialist, ear, nose and throat surgeon or neurologist, and children with suspected Kawasaki disease or IgA vasculitis are usually managed by pediatricians.

At what point should I see a rheumatologist?

When a systemic pattern such as fatigue, fever or weight loss is combined with raised inflammation markers and any sign of organ involvement, including blood or protein in the urine, a non-blanching rash, new numbness or sinus and lung symptoms. Stable, skin-only findings can usually wait for a routine appointment; worsening kidney results, lung or nerve symptoms should be referred urgently, and visual change or coughing blood belong in emergency care.

What test confirms vasculitis?

No single test confirms it. Diagnosis combines inflammation markers such as ESR and CRP, kidney function and urine microscopy, ANCA antibody tests, imaging of the vessels by ultrasound, CT or MR angiography or PET, and a biopsy of affected tissue. Mayo Clinic describes biopsy showing inflammatory cells in a vessel wall as the most definitive finding, though a negative biopsy does not rule the condition out because inflammation is patchy.

Is vasculitis a medical emergency?

It can be. Some forms are managed entirely in clinic, but certain features are emergencies: any change in vision, coughing up blood or sudden breathlessness, stroke-like symptoms, severe abdominal or chest pain, a sharp fall in urine output, or fever while on immune-suppressing medicine. These need same-day emergency care because the window to protect an organ can be short. Stable skin-only disease with normal organ tests is not usually an emergency.

How long is a hospital stay for vasculitis?

It varies with the reason for admission, and no reliable typical figure applies across all types. Someone admitted for a first intravenous treatment and a kidney biopsy may be home within days, while lung hemorrhage or rapidly failing kidneys can need a longer stay, sometimes with intensive care. Your team can give a personal estimate based on how quickly your organ tests respond and which treatments must be given in hospital.

Can vasculitis be treated without being admitted?

Often, yes. Skin-limited disease, IgA vasculitis in children without kidney involvement, giant cell arteritis with intact vision and most maintenance-phase care are managed as an outpatient with oral medicines and regular blood and urine monitoring. Admission is reserved for organs that are deteriorating faster than clinic visits can track, for intravenous treatment or plasma exchange, and for serious infection while immune-suppressed. Many people move from ward to clinic within weeks.

Does a negative ANCA test rule out vasculitis?

No. Several types of vasculitis are ANCA-negative by nature, including giant cell arteritis, Takayasu arteritis, polyarteritis nodosa and IgA vasculitis, and Johns Hopkins notes that some people with ANCA-associated disease also test negative. ANCA is one supporting piece of evidence. When the clinical picture, imaging or biopsy point toward vasculitis, a negative antibody test does not close the case, and your team may repeat it or rely on tissue.

What happens if vasculitis is not treated quickly?

The risk depends on the organ involved. Untreated kidney inflammation can progress to permanent loss of function and dialysis, giant cell arteritis can cause irreversible vision loss, and lung hemorrhage can be life-threatening. The NHS and Mayo Clinic both emphasize that early treatment can prevent lasting organ damage. Skin-only disease carries far less risk, which is why urgency is graded by which organs are affected rather than by the diagnosis alone.

Will I need to see a rheumatologist for life?

Many people remain under long-term follow-up, because vasculitis can relapse, sometimes years after a quiet period, and kidney relapse can be silent. Visit frequency usually falls from weeks apart during treatment to months apart in stable remission, and some types, such as IgA vasculitis in children, may be discharged after a period of clear urine checks. The length of follow-up is decided by your team based on your type and history.

References

• NHS: Vasculitis
• NHS: Temporal arteritis (giant cell arteritis)
• MedlinePlus: Vasculitis

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.